This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

2019 Program 
8th Canadian Sympsium on Hepatitis C

friday May 24, 2019

7:15 AM - 7:00 PM
Registration/Breakfast Inscription, Petit Déjeuner

8:00 - 8:15 AM
Welcome and Introductions - Mot de Bienvenue
Naglaa Shoukry, Université de Montréal

8:15 - 9:50 AM
Session #1: Biomedical Research

Co-Chairs: Rod Russell, Memorial University & Vanessa Meier-Stephenson, University of Calgary

8:15 - 8:35 AM
Remaining Challenges in HCV Research, Ralf Bartenschalger, Heidelberg University
8:35 - 8:55 AM
Single-Cell RNA Sequencing to Describe the Cellular Microenvironment of the Liver, Sonya MacParland, University of Toronto
8:55 - 9:15 AM
Questions and Panel Discussion
9:15 - 9:27 AM
Targeting HCV-induced Epigenetic Reprogramming for HCC Chemoprevention Post Cure, Nourdine Hamdane, University of Strasbourg
9:27 - 9:39 AM
Identification of the Domain to which miR122 and Other Small RNAs Annealing Promotes the HCV Lifecycle, Rasika Kunden, University of Saskatchewan
9:39 - 9:51 AM
Analysis of Programmed Cell Death Induced by HCV Infection, Lingyan Wang, Memorial University

9:51 - 10:10
Coffee Break

10:10 - 11:34 AM
Session #2: Social, Cultural, Environmental and Population Health Research

Co-Chairs: Marina Klein, McGill University & Abdool Yasseen, University of Toronto

10:10 - 10:30 AM
Diagnostic Testing for Hepatitis C Infection: Where Are We Now and What Does the Future Hold, Stuart C. Ray, Johns Hopkins University School of Medicine
10:30 - 10:50 AM
Hepatitis C & HIV Testing from Dried Blood Spots: Simplifying Testing to Broaden Community Based Testing, John Kim, Public Health Agency of Canada
10:50 - 11:11 AM
Questions and Panel Discussion 11:11 - 11:22 AM: Estimation of an Individual-Level Deprivation Index for HIV/HCV Co-Infected Persons, Adam Palayew, McGill University
11:22 - 11:34 AM
Opioid Agonist Treatment and Risk of Hepatitis C Virus Infection Among People who Inject Drugs: The Overlooked Role of Dosage Adequacy, Andreea Adelina Artenie, Université de Montréal

11:34 - 1:00 PM
Lunch & Poster Sessions
Posters will be evaluated between

1:00 - 2:36 PM
Session #3: Clinical Research

Co-Chairs: Lisa Barrett, Dalhousie University & Sahar Saeed, McGill University

1:00 - 1:20 PM
Risk of HCC Following Hepatitis C Treatment, Hashem B. El-Seraq, Baylor College of Medicine
1:20 - 1:40 PM
Liver Fibrosis Staging in Hepatitis C, Keyur Patel, University Health Network
1:40 - 2:00 PM
Questions and Panel Discussion
2:00 - 2:12 PM
Never too Old to be DAA Treated for Hepatitis C, Curtis Cooper, University of Ottawa
2:12 - 2:24 PM
Feasibility of Rapid Hepatitis C Point-of-Care RNA Testing and Linkage to Care at an Integrated Supervised Consumption Site in Toronto, Canada, Bernadette Lettner, South Riverdale Community Health Centre
2:24 - 2:36 PM
Engaging Vulnerable, Treatment Naïve Persons Living with Hepatitis C in Same-Day Treatment, Shawn Greenan, Health PEI

2:36 - 2:56 PM
Coffee Break

2:56 - 5:15 PM
Session #4: Health Services Research

Co-Chairs: Naveed Janjua University of British Columbia & Aysegul Erman, University of Toronto

2:56 - 3:16 PM
Scaling Up HCV Screening & Diagnosis to Eliminate HCV, Jagpreet Chhatwal, Harvard Medical School
3:16 - 3:36 PM
Testing & Linkage with Care Strategies for HCV Among Immigrants & Newcomers, Christina Greenaway, McGill University
3:36 - 3:56 PM
Questions and Panel Discussion
3:56 - 4:08 PM
The Hepatitis C Virus (HCV) Cascade of Care in a Canadian Provincial Prison, Implications for HCV Micro-Elimination, Nadine Kronfli, McGill University
4:08 - 4:20 PM
State-Specific Direct Medical Costs of Hepatitis C in Ontario: A Population-Level Study, Alexander Haines, Toronto Health Economics and Technology Assessment Collaborative
4:20 - 4:32 PM
Assessment of Hepatitis C Screening Strategies in Different Community Settings in a Canadian Metropolitan Area, Camelia Capraru, Toronto Centre for Liver Disease/VIRCAN, UHN
4:32 - 5:15 PM
Improving Hepatitis C Diagnosis & Linkage to Care: Engaging Peers with Lived Experience in Programming & Research, Moderator: Chris Hoy, CATIE

5:15 - 5:25 PM
CanHepC Trainee Awards Ceremony

5:25 - 5:30 PM
CanHepC Symposium Closing Remarks Selena Sagan & Giada Sebastini, McGill University

5:30 - 5:40 PM
Canadian Liver Meeting Opening Remarks Marc Bilodeau, Université de Montréal

5:40 - 6:30 PM
Blueprint to Inform Hepatitis C Elimination Efforts in Canada
Jordan Feld, University of Toronto

6:30 PM
Canadian Liver Meeting Opening Reception